Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-08

FDA Approved: KATERZIA — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves KATERZIA (amlodipine) through an Original Application by Azurity Pharmaceuticals, introducing an amlodipine oral suspension. The product targets hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KATERZIA (AMLODIPINE)

Snippet

ORIG AP for KATERZIA (AMLODIPINE)